VIATRIS INC. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- VIATRIS INC. treasury stock, shares, acquired for the quarter ending 2026-06-30 was 9.40M shares, a 53.47% decline year-over-year.
- VIATRIS INC. treasury stock, shares, acquired for the quarter ending 2025-09-30 was 6.80M shares.
- VIATRIS INC. treasury stock, shares, acquired for the quarter ending 2025-06-30 was 20.20M shares.
- VIATRIS INC. treasury stock, shares, acquired for the quarter ending 2025-03-31 was 18.60M shares, a 3.13% decline year-over-year.
- VIATRIS INC. treasury stock, shares, acquired for fiscal 2018 was 9.80M shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2026-06-30 | 9.40M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 6.80M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 20.20M shares 10-Q · filed 2026-08-06 | |
| 2025-03-31 | 18.60M shares 10-Q · filed 2025-05-08 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | |
| 2024-03-31 | 19.20M shares 10-Q · filed 2025-05-08 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | |
| 2023-03-31 | 21.20M shares 10-Q · filed 2024-05-09 | |
| 2018-12-31 | 9.80M shares 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |